These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26171401)

  • 1. Use of Insulin and Mortality from Breast Cancer among Taiwanese Women with Diabetes.
    Tseng CH
    J Diabetes Res; 2015; 2015():678756. PubMed ID: 26171401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.
    Tseng CH
    BJU Int; 2012 Sep; 110(5):668-73. PubMed ID: 22300458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin use and smoking jointly increase the risk of bladder cancer mortality in patients with type 2 diabetes.
    Tseng CH
    Clin Genitourin Cancer; 2013 Dec; 11(4):508-14. PubMed ID: 23791436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
    Calip GS; Yu O; Elmore JG; Boudreau DM
    Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan.
    Tseng CH
    Acta Diabetol; 2013 Dec; 50(6):879-86. PubMed ID: 23508375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes but not insulin is associated with higher colon cancer mortality.
    Tseng CH
    World J Gastroenterol; 2012 Aug; 18(31):4182-90. PubMed ID: 22919252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort.
    Chen CZ; Hsu CH; Li CY; Hsiue TR
    J Asthma; 2017 Dec; 54(10):1019-1025. PubMed ID: 28135899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan.
    Yang YS; Kornelius E; Chiou JY; Lai YR; Lo SC; Peng CH; Huang CN
    J Womens Health (Larchmt); 2017 Dec; 26(12):1278-1284. PubMed ID: 28537451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.
    Liao KF; Lai SW; Li CI; Chen WC
    J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan.
    Tseng CH
    Metabolism; 2012 Jul; 61(7):1003-9. PubMed ID: 22237115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
    Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
    Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
    Bowker SL; Lin M; Eurich DT; Johnson JA
    Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.